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science researchers for retrieving experts’ knowledge stored 
in the databases and for building a new hypothesis of the 
research target. This web application, named VaProS, puts 
stress on the interconnection between the functional infor-
mation of genome sequences and protein 3D structures, 
such as structural effect of the gene mutation. In this manu-
script, we present the notion of VaProS, the databases and 
tools that can be accessed without any knowledge of data-
base locations and data formats, and the power of search 
exemplified in quest of the molecular mechanisms of lys-
osomal storage disease. VaProS can be freely accessed at 
http://p4d-info.nig.ac.jp/vapros/.
Keywords Big data analysis · Database integration · 
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Introduction
The advance of the molecular biology has yielded a huge 
amount of biological data including DNA/RNA/protein 
sequences [1–3], their expression levels [4], difference in 
the sequences of individuals [5], three-dimensional (3D) 
structures of the biomolecules [6], phenotypes of the organ-
isms [7] and so forth. These data have been stored in inde-
pendent databases located on the Internet and researchers 
exploit these databases for new knowledge of the target 
of their study. Database mining facilitates the process of 
knowledge acquisition and that of building new hypotheses 
for planning new experiments [8].
The expansion of the data size has been coped with the 
increase in the size of the storage and with invention of a 
new algorithm for searching the whole data swiftly. One 
of the famous examples of the tool for quick search of a 
database in this field is BLAST [9], a tool to search similar 
Abstract Life science research now heavily relies on all 
sorts of databases for genome sequences, transcription, 
protein three-dimensional (3D) structures, protein–pro-
tein interactions, phenotypes and so forth. The knowledge 
accumulated by all the omics research is so vast that a com-
puter-aided search of data is now a prerequisite for starting 
a new study. In addition, a combinatory search throughout 
these databases has a chance to extract new ideas and new 
hypotheses that can be examined by wet-lab experiments. 
By virtually integrating the related databases on the Inter-
net, we have built a new web application that facilitates life 
 * Kei Yura 
 yura.kei@ocha.ac.jp
1 Computational Bioscience Research Center, Biological 
and Environmental Sciences and Engineering, King Abdullah 
University of Science and Technology, Thuwal 23955-6900, 
Saudi Arabia
2 National Institute of Genetics, Shizuoka, 411-8540 Mishima, 
Japan
3 Graduate School of Agricultural and Life Sciences, 
University of Tokyo, Bunkyo, Tokyo 113-8657, Japan
4 Institute for Protein Research, Osaka University, Suita, 
Osaka 565-0871, Japan
5 Graduate School of Information Sciences, Tohoku 
University, Miyagi, Sendai 980-8597, Japan
6 Tohoku Medical Megabank Organization, Tohoku 
University, Miyagi, Sendai 980-8573, Japan
7 Department of Maternal-Fetal Biology, National Research 
Institute for Child Health and Development, Setagaya, 
Tokyo 157-8535, Japan
8 Department of Pediatrics, St. Marianna University School 
of Medicine, Miyamae, Kawasaki 216-8511, Japan
9 Center for Informational Biology, Ochanomizu University, 
2-1-1, Otsuka, Bunkyo, Tokyo 112-8610, Japan
70 T. Gojobori et al.
1 3
sequences out of the huge nucleotide/amino acid sequence 
databases. Further expansion of the size of the independ-
ent database and the increase in the variety of databases 
may have enhanced chances for performing novel experi-
ments by extending the scope of hypotheses, yet the lack 
of technology for integrating different types of databases 
and of an application for searching the multiple databases 
have precluded extensive application of this approach. The 
researchers aiming for an integrated search of different 
databases should approach the databases one by one, learn 
how to use each database and obtain information relevant 
for their studies. The users then integrate the data obtained 
from different databases by themselves. This process evi-
dently requires tedious labour as well as skills for manipu-
lating data in different formats. Hence, the biggest hurdle 
that we have to overcome in the current life science activity 
is the complexity in integrating databases in a way that ena-
bles us to come up with novel ideas and hypotheses. Once 
the up-to-date data is comprehensively integrated, then 
researchers with an experience in a specific field can start 
deducing a hypothesis in a data-driven manner.
The effort for integrating the management of different 
databases has been made by a number of groups [10–14]. 
Linking data with a common framework is one of the pos-
sible approaches, and the Semantic Web technologies are 
becoming increasingly popular in recent years [15]. While 
the Semantic Web technologies based on linked open data 
and ontologies are a promising approach, extremely diverse 
set of ontologies as well as non-uniform uses of URI (Uni-
form Resource Identifiers) to describe identical resources 
by different parties make it difficult to integrate various 
information resources without extensive manual interven-
tion. Although some efforts have been dedicated to solve 
these difficulties (e.g., http://identifiers.org), it will take 
time for the research community to agree on a unified 
convention.
To overcome these difficulties in a search of multiple 
databases in the information of life science, we started 
developing a new type of application that searches data-
bases in different locations simultaneously by a simple 
search query and displays the result in a simple interface at 
http://p4d-info.nig.ac.jp/vapros/. We named the application 
VaProS, VAriation effect of PROtein Structure and func-
tion. The name derived from the aim of the application, 
namely to focus on analysing effects of DNA sequence var-
iations on protein structures and function. VaProS aims to 
realize an idea of “data cloud”, that is to retrieve data with-
out any knowledge of databases scattered in the Internet.
The idea embedded in VaProS that is different from 
other general database integration efforts is that VaProS 
makes much of the relationship among the biological mol-
ecules and phenomena. The relationship is governed by the 
central dogma; hence all the incidents can be described in 
either gene-centered or protein-centered manner. Pheno-
typic changes of an organism likely derive from changes in 
the biological system of the organism, which is sustained 
by the network of biomolecules and those biomolecules 
are ultimately encoded in DNA. This flow of information 
is nothing but the opposite direction of the central dogma, 
and hence the organization of data and databases in VaProS 
follows the information flow in the central dogma. Techni-
cally, the search results of the variety of databases are inter-
connected using the protein as a hub of information. In the 
following sections, the detail of VaProS and the example of 
the usage are presented.
Materials and methods
Databases and tools on the internet
Table  1 lists the databases that are integrated on VaProS 
and the tools that visualize the search results. There are 16 
databases and 15 tools of which VaProS are made. The lat-
est information of the databases, namely the version and 
the size, is given at http://p4d-info.nig.ac.jp/vapros/statis-
tics.html. The integration of the databases took the form of 
either dynamic link or a data copy from the original site to 
the local site of VaProS. Ideally, all the databases should 
be accessed dynamically to avoid time lag of the data and 
to save the local disk space, but such dynamic access often 
sacrifices a prompt response to a query. Therefore, we 
downloaded the part of the data from each database and 
achieved an optimum response speed. The data update is 
scheduled once in every six month to keep abreast with 
the latest data in all the databases. VaProS deals with the 
data of humans, rats and mice and focuses on phenomena 
related to humans.
Data integration and data presentation in VaProS
VaProS is unique in the style of data integration. VaProS 
tries to integrate different databases dynamically and rela-
tionship amongst the data in the databases is taken by Uni-
Prot accession key. Central dogma guarantees the relation-
ship between biomolecules in the organisms, hence all the 
phenotypes should basically stem from the perturbation 
on biomolecules. Therefore, phenomena observed in the 
organization can be tagged to either DNA or protein. We 
chose a protein identifier to tag all the other data, because 
VaProS is aimed for the analysis of protein variation.
UniProtKB [2], GeneCards [12] and Cosmic [13] 
assume a similar approach for the integration of relevant 
data. VaProS put stress on a graphical presentation of the 
search results as found in “Molecular Interactions” and 
“TagCloud”, and on the analyses on protein 3D structures 
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Table 1  Components of VaProS
DB/tool name Data resource Search tool Data/function used in 
VaProS
Method of access Original location Reference
EntrezGene ✓ Nomenclature, reference 
and other biological infor-
mation of genes
Copy and link http://www.ncbi.nlm.nih.
gov/gene/
[16]
UniprotKB ✓ Amino acid sequences with 
biological annotation 
such as ontology and clas-
sification
Copy and link http://www.uniprot.org/ [17]
BioGRID ✓ Genetic and protein interac-
tions with curation based 
on biomedical literature
Copy and link http://thebiogrid.org/ [18]
ChEMBL ✓ Drug-like small molecules 
with interacting proteins
Copy and link https://www.ebi.ac.uk/
chembl/
[19]
DrugBank ✓ Drug molecules com-
bined with drug target 
informtaion
Copy and link http://www.drugbank.ca/ [20]
IntAct ✓ Molecular interactions 
obtained from literature 
and direct submission
Copy and link http://www.ebi.ac.uk/intact/ [21]
PID (NDEx) ✓ Biological interaction data 
of proteins
Copy and link http://www.ndexbio.org/#/ [22]
Reactome ✓ Biological pathway data Copy and link http://www.reactome.org/ [23]
OMIM ✓ Mendelian disease related 
phenotype and its causa-
tive gene
Link http://www.omim.org/ [7]
hGtoP ✓ ✓ 3D structural and compara-
tive genomics annotations 




Natural Ligand Database ✓ ✓ 3D models of proteins and 
their natural ligands reg-
istered in KEGG reaction 
database
Link http://nldb.hgc.jp/nldb/ [25]
COXPRESdb ✓ ✓ Relationship of gene 
expression based on 
RNAseq and microarray 
data
Link http://coxpresdb.jp/ [26]
Mutation@A Glance ✓ ✓ Genetic variants on proteins 
including disease-causing 





3D Interaction ✓ ✓ Models of protein 3D 
structure and the structure 
in complex with other 
molecules
Link http://homcos.pdbj.org/ [28]





GNP expression ✓ ✓ Genes clustered by expres-






Molecular Interactions ✓ Graphic tool for interac-
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as found in “hGtoP”, “3D Interaction” and “Natural Ligand 
Database”.
Search method
VaProS accepts keywords, DNA/protein sequence, Entrez-
Gene ID and UniProtKB accession as a query (Fig.  1). 
A keyword can be a gene name, a protein name, a ligand 
(drug) name, a disease (phenotype) name and an identifier 
found in the databases. Input of the keywords is assisted by 
a keyword-suggestion function. Incomplete input makes 
VaProS find a related keywords in the keyword database 
and it shows a list of candidate words below the query input 
window. Once the Search button is pressed, VaProS throws 
the input data to NOREN, an original tool to search for 
whole IDs in the databases related to the query. NOREN 
is based on the ID mapping table provided by UniProtKB 
[2], and BLAST [9]. The result of the query is presented 
as a list of candidates to the user. The candidate list is cat-
egorized into three different types, namely Gene/Protein, 
Ligand and Phenotype (Fig.  2). The user may select the 
most relevant element in the list, press “Details (Go)” but-
ton and obtain the results of the search done by IDs relevant 
to the keywords (Fig. 3). The results are presented through 
the tools tabulated in Table 1. The search results shown by 
each tool can be opened by clicking the corresponding icon 
on the left in Fig. 3.
Results and discussion
We explored the current knowledge on lysosomal storage 
diseases (LSDs) and built a tenable hypothesis as a case 
study to show the usage of VaProS. The similar analyses 
can be conducted on different diseases by accessing http://
p4d-info.nig.ac.jp/vapros.
Lysosomal storage disease
Lysosomes are subcellular organelles responsible for the 
physiological turnover of the cell constituents. They con-
tain catabolic enzymes that require a low pH environment 
for their optimal function. LSDs are a heterogeneous group 
of more than 50 rare inherited disorders characterized by 
the accumulation of undigested or partially digested mac-
romolecules (Table  2). LSDs ultimately result in cellular 
dysfunction and clinical abnormalities. LSDs are caused 
by deficiencies or defects in enzymes for lysosomes, in 
proteins necessary for the normal post-translational modi-
fication of lysosomal enzymes, in the activator proteins 
Table 1  (continued)
DB/tool name Data resource Search tool Data/function used in 
VaProS
Method of access Original location Reference
TagCloud ✓ Graphic tool to display 
frequency of words in the 
titles of papers registered 
in UniProt
Built-in – –
Pathway DB ✓ Finder of the related path-
ways from the databases 
in use
Built-in – –
Phenotype ✓ Finder of medelian disease 
related to the protein/gene 
in query
Built-in – –
Cis-finder ✓ Finder of the cis element 
candidate motifs in DNA 
sequence
Built-in – –
S-VAR ✓ Evaluator of the impact of 





Genome explorer ✓ Annotator of genes with 
transcription start sites 





NOREN ✓ ID connector from UniProt 
AC to all the other IDs of 
the databases in use
Built-in http://cib.cf.ocha.ac.jp/DC/ –
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of lysosomal enzymes, and in the proteins important for 
proper intracellular trafficking between the lysosome and 
other intracellular compartments. The individual dis-
eases are rare, but LSDs as a group affects many people 
around the world with a frequency of about one in every 
7000–8000 live births [30, 31].
Search in the first step
A search by a keyword “gangliosidosis”, one of the major 
groups in LSDs, resulted in six candidates as shown in 
Fig. 4. As shown in Table 2, gangliosidoses are classified 
into two types, GM1 and GM2, both of which are further 
classified into three subtypes. The estimated incidence of 
GM1-gangliosidosis is 1 per 100,000 to 200,000 births, and 
those of GM2-gangliosidosis are 1 per 360,000 births for 
Tay-Sachs disease and 1 per 310,000 or 1,000,000 births 
for Sandhoff disease. GM2-gangliosidosis AB variant is 
extremely rare [32]. Each line in the search result happened 
to correspond to an individual entry of genetic diseases/
disorders in OMIM database [7]. The three types in GM1-
gangliosidoses (types I, II, and III) were related to the same 
“Molecule Symbol”, namely GLB1 gene, but Tay-Sachs 
disease, Sandhoff disease and AB variant in GM2-gangli-
osidoses were related to HEXA, HEXB and GM2A genes, 
respectively. Each gene was linked to the databases listed 
in Table 1. Ticking the far left box in Fig. 4 and pressing 
“Details (Go)” button on the top led the user to the further 
detail of the selected item. In the following section, the 
search result of each tool listed in Table 1 is explained.
Molecular interactions
The interaction network of the proteins encoded in 
HEXA and HEXB was found in “Molecular Interactions” 
window (Fig. 5). This window can be displayed by tick-
ing both HEXA and HEXB in the table shown in Fig. 4 
and pressing “Details (Go)” button. A protein is repre-
sented with a big node and a ligand is represented with a 
small node. A protein–protein/ligand interaction is repre-
sented with an edge. Figure 5 tells that eight proteins and 
four ligands interact both with HEXA and HEXB, and 
each protein interacts with a number of other proteins and 
ligands. These interactions were extracted from different 
Fig. 1  The top page of VaProS located at http://p4d-info.nig.ac.jp/vapros
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databases listed in Table  1. In Fig.  5, the nodes in red 
are proteins associated with diseases. The information 
was extracted from OMIM (Table 1), and the catalog of 
specific disease is given on the right side of the window. 
There are two nodes in red that interact with both HEXA 
and HEXB, which suggest disease–disease interactions. 
By right clicking a node, protein–protein interactions can 
be extended. The pathway of two nodes in the window 
Fig. 2  The initial search result by VaProS. The query word is “HEXA”, the causative gene of Tay-Sachs disease
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can be automatically detected using “Path Search” on the 
top menu.
By clicking a node or an edge, the detail information of 
the node/edge can be displayed on the right bottom of the 
window. In Fig. 5, HEXA was selected, hence the detail of 
HEXA was presented on the right. The link to “3D Interac-
tion” shows the protein 3D structural information of HEXA 
protein. In 3D Interaction, SiteTable/SitesByVariants link 
leads the users to the information that VaProS aims for, 
namely the relationship between variations on DNA and 
protein structure/function.
TagCloud
An overview of the target protein can be obtained by ana-
lyzing the frequency of words in the manuscripts related 
to the protein. Figure  6 is the result of such analysis on 
the titles of papers registered in UniProtKB under the 
entry HEXA. TagCloud emphasizes words that frequently 
appear in the titles of these papers by enlarging the size of 
the fonts. Visual inspection of TagCloud makes us recog-
nize that HEXA protein is beta-hexosaminidase and may 
be a multimeric protein. TagCloud also ascertains that the 
protein is connected with the notion of disease. These facts 
are trivial for specialists in the field, but are not so for the 
researchers in different fields and are valuable information 
for the interdisciplinary study. The list of the papers using 
the word in the title can be found by clicking the word in 
the TagCloud.
hGtoP
hGtoP provides relationship between genes and proteins as 
its name suggested (G in hGtoP stands for Gene/Genome 
and P for Protein). The original GtoP was developed by 
Kawabata et al. [24]. VaProS included human specific GtoP 
as one of the tools. With hGtoP, the structural informa-
tion of the protein in the query is easily found. In addition, 
the homologues of the protein in different species can be 
found. “3D Interaction” and “hGtoP” contain similar infor-
mation about protein 3D structures, however, the former 
focuses more on 3D modelling of complex structures, and 
the latter focuses on comparative genomics. PDB infor-
mation in Table 2 was obtained by hGtoP and 3D Interac-
tion. The information clarified that some of the proteins 
in LSDs do not have structural information yet. In other 
Fig. 3  The search result in detail by pressing the “Details (Go)” button in Fig. 2. The protein–protein interactions and frequently used terms in 
literature related to HEXA are displayed
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Table 2  Lysosomal storage diseases
Disease Type Gene UniProt ID PDB PDB identity*
Mucopolysaccharidosis IH (Hurler syndrome) – – – –
IH-S (Hurler-Scheie syndrome) IDUA IDUA_HUMAN 3W81 100%
IS (Hurler, Hurler/Scheie, Scheie syndrome) – – – –
II (Hunter syndrome) IDS IDS_HUMAN 4UG4 36%
III-A (Sanfilippo syndrome) SGSH SPHM_HUMAN 4MIV 100%
III-B NAGLU ANAG_HUMAN 4XWH 100%
III-C HGSNAT HGNAT_HUMAN – –
III-D GNS GNS_HUMAN 4UG4 30%
IV-A (Morquio syndrome) GALNS GALNS_HUMAN 4FDI 100%
IV-B GLB1 BGAL_HUMAN 3WF2 100%
VI (Maroteaux-Lamy syndrome) ARSB ARSB_HUMAN 1FSU 100%
VII (Sly syndrome) GUSB BGLR_HUMAN 1BHG 100%
IX (Hyaluronidase deficiency) HYAL1 HYAL1_HUMAN 2PE4 99%
Niemann-Pick disease A SMPD1 ASM_HUMAN 5FC5 35%
B – – – –
C1 NPC1 NPC1_HUMAN 3JD8 100%
C2 NPC2 NPC2_HUMAN 2HKA 80%
GM1 gangliosidosis I GLB1 BGAL_HUMAN 3WF2 100%
II GLB1 BGAL_HUMAN 3WF2 100%
III GLB1 BGAL_HUMAN 3WF2 100%
GM2 gangliosidosis Tay-Sachs disease HEXA HEXA_HUMAN 2GJX 99%
Sandhoff’s disease HEXB HEXB_HUMAN 5BRO 98%
AB variant GM2A SAP3_HUMAN 1PUB 100%
Sulfatide lipidosis Metachromatic leukodystrophy ARSA ARSA_HUMAN 1N2L 100%
ARSA ARSA_HUMAN 1N2L 100%
Multiple sulfatase Deficiency ARSB ARSB_HUMAN 1FSU 100%
SUMF1 SUMF1_HUMAN 1Y1H 100%
Saposin dificiency Prosaposin deficiency – – 4V2O 100% (frag-
ments)Krabbe disease, atypical – – 3BQQ
Saposin B deficiency PSAP SAP_HUMAN 2DOB
Gaucher disease, atypical – – 1SN6
Glycogenosis II (Pompe disease) GAA LYAG_HUMAN 2QLY 47%
Gaucher disease Gaucher disease GBA GLCM_HUMAN 2WKL 100%
Fabry disease Fabry disease GLA AGAL_HUMAN 3LXB 99%
Ceramidosis Farber’s disease ASAH1 ASAH1_HUMAN – –
Krabbe disease Krabbe disease GALC GALC_HUMAN 4UFH 84%
Cholesterol ester storage disease Cholesterol ester storage disease LIPA LICH_HUMAN 1K8Q 60%
Wolman disease Wolman disease
Glycoprotein disorder Alpha-fucosidosis FUCA1 FUCO_HUMAN 2ZXA 39%
Alpha-mannosidosis MAN2B1 MA2B1_HUMAN 1O7D 83%
Beta-mannosidosis MANBA MANBA_HUMAN 2VR4 31%
Aspartylglycosaminuria AGA ASPG_HUMAN 1APZ 99%
Galactosialidosis CTSA PPGB_HUMAN 1IVY 99%
Mucolipidosis I NEU1 NEUR1_HUMAN 1EUS 37%
Mucolipidosis II – – – –
Mucolipidosis III GNPTAB GNPTA_HUMAN 2N6D 99% (fragment)
Schindler’s disease NAGA NAGAB_HUMAN 4DO4 99%
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words, Table 2 provides valuable information for structural 
genomes of LSDs, namely the target proteins for determin-
ing 3D structures.
Natural ligand database
Natural Ligand Database (NLDB) [25] provides the 
model of protein structures with natural ligands. The idea 
stemmed from the fact that many ligands in PDB are modi-
fied ligands for the sake of crystallisation and the bridge 
between those modified ligands and natural ligands should 
be provided to enhance the 3D structural information in 
PDB. The search query “GM1 gangliosidosis” led the 
user to the causative gene GLB1. NLDB demonstrated 
that GLB1 was involved in 15 KEGG reactions, and these 
15 reactions were classified into five pathways according 
to “UniProt search view”. The same 15 reactions can be 
found in “Pathway DB” tool (Table  1). Of the five path-
ways in NLDB, glycosphingolipid biosynthesis (hsa00604) 
contained the reaction of GM1 degradation (R06010). 
In this reaction, 56 natural ligand complexes were regis-
tered in NLDB derived from the proteins of various spe-
cies. The link to human beta-galactosidase, the product of 
GLB1 gene, with galactose (PDB ID: 3THC) led to the 3D 
Table 2  (continued)
Disease Type Gene UniProt ID PDB PDB identity*
Membrane metabolism disorder Cystinosis CTNS CTNS_HUMAN – –
Sialic acid storage disease (Salla disease) SLC17A5 S17A5_HUMAN – –
Cathepsin K deficiency disease (pycnodys-
ostosis)
CTSK CATK_HUMAN 7PCK 100%
Cobalamin F disease (cblF) LMBRD1 LMBD1_HUMAN – –
Danon disease LAMP2 LAMP2_HUMAN 2MOM 100% (fragment)
Neuronal Ceroid Lipofuscinosis Neuronal ceroid lipofuscinosis-1 PPT1 PPT1_HUMAN 3GRO 100%
Neuronal ceroid lipofuscinosis-2 TPP1 TPP1_HUMAN 3EDY 100%
Neuronal ceroid lipofuscinosis-3 CLN3 CLN3_HUMAN – –
Neuronal ceroid lipofuscinosis-4A CLN6 CLN6_HUMAN – –
Neuronal ceroid lipofuscinosis-4B DNAJC5 DNJC5_HUMAN 2CTW 100% (fragment)
Neuronal ceroid lipofuscinosis-5 CLN5 CLN5_HUMAN – –
Neuronal ceroid lipofuscinosis-6 CLN6 CLN6_HUMAN – –
Neuronal ceroid lipofuscinosis-7 MFSD8 MFSD8_HUMAN – –
Neuronal ceroid lipofuscinosis-8 CLN8 CLN8_HUMAN – –
Neuronal ceroid lipofuscinosis-10 CTSD CATD_HUMAN 2PSG 49%
Neuronal ceroid lipofuscinosis-11 GRN GRN_HUMAN 2JYE 100% (fragment)
Neuronal ceroid lipofuscinosis-12 ATP13A2 AT132_HUMAN 3WGV 27%
Neuronal ceroid lipofuscinosis-13 CTSF CATF_HUMAN 1M6D 99%
Neuronal ceroid lipofuscinosis-14 KCTD7 KCTD7_HUMAN 4UES 50% (fragment)
Congenital disorder of glycosylation IA PMM2 PMM2_HUMAN 2AMY 100%
*Amino acid sequence identity between the UniProt and PDB entries
Fig. 4  Initial search result by VaProS. The search by “gangliosidosis” initially results in a table of candidates
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structures of the ligand–protein complex with reported var-
iation in amino acid residues. The variations in amino acid 
residues around the ligand-binding site were highlighted 
on the table of NLDB window. In this entry, ten variations 
were reported around the ligand-binding site, and eight of 
them were related to diseases, namely three to GM1 type I, 
one to GM1 type II, one to GM1 type III, and two to muco-
polysaccharidosis IV-B.
COXPRESdb
Gene co-expression sometimes sheds light on relation-
ship between genes, and COXPRESdb [26] provides user-
friendly interface to gene co-expression information in 
humans, mice and rats. The search query “GM2 gangliosi-
dosis” on VaProS led the user to a list of causative genes 
that included HEXA and HEXB. COXPRESdb demon-
strated that the co-expression for HEXA (PCC = 0.43) and 
HEXB (PCC = 0.45), which are known to be related with 
Sandhoff disease and Tay-Sachs disease, respectively from 
OMIM information. By following the link to COXPRESdb, 
the user can also check the co-expression networks of 
HEXA and HEXB, which led to the finding that ten more 
lysosomal proteins are tightly co-expressed with them.
Other tools
GNP Expression, Phenotype, Autophagy DB, Genome 
Explorer and Mutation@A Glance (Table  1) show the 
search results in a tabulated or graphical form. The user can 
further analyze the database of each tool by following the 
link in the search result.
Fig. 5  “Molecular Interactions” after selecting HEXA and HEXB in 
the initial search result (Fig.  4). A big node represents a protein, a 
small node represents a ligand and an edge represents a protein–pro-
tein/ligand interaction. A node in red is associated with a disease 
(selected in the top-right window)
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S-VAR is a special tool that evaluates impact of amino 
acid substitution to the function of the protein. By pro-
viding a specific mutation to the window of S-VAR, the 
tool starts a couple of software that evaluate the impact 
of the mutation [33–36] and provides each and consensus 
results for the user at some intervals.
Fig. 6  Artistic representation 
of the frequency of words in the 
titles of the manuscripts stored 
in the entry of HEXA_HUMAN 
in UniProtKB. The visualiza-
tion was realized by d3-cloud 
(https://github.com/jasondavies/
d3-cloud)
Fig. 7  Variations of GM1-gangliosidosis mapped onto the protein 3D structure of GLB1. Variations in type I (a) and variations in type III (b). 
The structure of human β-galactosidase (PDB ID: 3WF2) is used for the mapping
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Building hypothesis on the relationship 
between phenotype and protein 3D structure
Combination of the search results in each tool can be 
a basis of building a hypothesis that can be verified by 
wet-lab experiments. The search query “GM1 gangliosi-
dosis” on VaProS led the user to the current knowledge 
that the causative gene is GLB1, which encodes lysoso-
mal enzyme β-D-galactosidase. By following the link to 
OMIM [7], user can acquire information on the detail of 
the disease, namely GM1 gangliosidosis is classified into 
three types in accordance with the onset age and severity; 
type I (infantile), type II (juvenile) and type III (adult) as 
shown in Table 2.
“3D Interaction” summarized the variations leading to 
each type of diseases on the protein 3D structure (Fig. 7). 
Visual inspection of the figure tells that the variation 
tends to be located inside the protein. Indeed, the ratios 
of buried residues for type I was 95.5%, for type II was 
88.2%, and for type III was 86.7%. These ratios are sig-
nificantly higher than the average of the protein (Table 3). 
Note that the ratio of buriedness of the variation site is 
highest in type I and lowest in type III. Generally, muta-
tions on the buried sites often make the protein less stable 
than the native one. Hence the observation suggests that 
the variations on type I have more impact on the stability 
of the protein than those on type III. 3D Interaction also 
provided amino acid frequencies of homologous proteins. 
The mutation to the rare amino acid implies that the type 
of amino acid has not sufficiently fixed during the molec-
ular evolution. The ratios of mutations to the amino acids 
that no homologues used were 78.4% (type I), 73.7% (type 
II) and 53.3% (type III). Serious phenotypes are expected 
by mutations to amino acid types rarely observed in hom-
ologues. The buriedness and trends in amino acid types 
between types I and III apparently correlated with the 
degree of seriousness in each type of GM1 gangliosi-
doses. The similar trend was discussed by Ohto et  al. at 
the time they determined the 3D structure of the protein 
[37]. VaProS enables such complex hypothesis building in 
a short period of time.
Conclusion
Here we launched VaProS, a new type of database integra-
tion application. VaProS enables a quick search of multi-
ple databases with interrelation of each search result. This 
application can be used as a textbook for acquiring expert 
knowledge for researchers in different fields, and can be a 
tool for building a data-driven hypothesis that can be tested 
by wet-lab experiments [16–23].
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